Recursion Pharmaceuticals RXRX faced a significant setback in May 2025 after announcing the discontinuation of three key drug candidates — REC-994, REC-2282, and REC-3964 — as part of its broader ...

D-Wave’s Q1 2025 revenue surged to $15 million, driven 85% by a single $12.6 million system sale. QCaaS revenue remained flat ...

If the rest of Nvidia's business grows by 10% during that time, then Nvidia's total revenue at the end of 2028 will be $311 billion. If Nvidia can maintain its 55% profit margin (it dipped in the most ...

In tandem with a presidential speech on Wednesday, the Trump administration is set to roll out its “AI Action Plan,” and new ...

Cipher Mining Inc. (NASDAQ:CIFR) is one of the top bitcoin mining stocks to buy amid bitcoin hike. On July 2, Cipher Mining ...

Artificial intelligence stocks are trading near their all-time high. But this stock is down 57% as it has not realized the AI ...

Although it is still working on that project, over the past two years, Meta's work in artificial intelligence (AI) has become ...

Key Points One of these stocks finished the first half unchanged, and the other fell in the double-digits.Both represent ...

With a self-funded model and a focus on high-unmet-need areas in neuroscience, Alkermes plc (NASDAQ:ALKS) continues to ...

ASML Holding reported strong Q2 results, but geopolitical risks cloud 2026 growth. Click for insights on ASML stock trends, ...

While the Nasdaq seems to reach new highs daily, enterprise tech spending remains persistently cautious at the macro amid ...

RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and BullFrog AI, Inc. (Nasdaq:BFRG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on ...